세계의 위풍선 시장에 관한 TMR의 리포트는 과거와 현재의 성장 동향 및 2023-2031년의 예측 기간 중 시장 지표의 귀중한 인사이트를 얻을 기회를 연구하고 있습니다. 리포트는 2023년을 기준년, 2031년을 예측년으로 간주하며, 2017-2031년 세계 위풍선 시장의 매출을 제공합니다. 리포트는 2023-2031년 세계 위풍선 시장의 연평균 성장률(CAGR %)도 제공합니다.
이 리포트는 광범위한 조사를 거쳐 작성되었습니다. 1차 조사에서는 조사 활동의 대부분을 시행하고 애널리스트가 주요 오피니언 리더, 업계 리더, 오피니언 제조업체와 인터뷰를 진행했습니다. 2차 조사에는 위풍선 시장을 이해하기 위해 주요 기업의 제품 문헌, 연차보고서, 프레스 릴리스 및 관련 문서의 참조가 포함됩니다.
이 리포트는 세계의 위풍선 시장의 경쟁 구도를 자세하게 조사하고 있습니다. 세계의 위풍선 시장에서 활동하는 주요 기업이 식별되고 각각의 기업이 다양한 속성의 관점에서 프로파일링되고 있습니다. 회사 개요, 재무 상황, 최근 동향, SWOT는 이 리포트에서 소개되고 있는 세계의 위풍선 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약 : 세계 시장
제4장 시장 개요
서론
개요
시장 역학
세계 시장의 분석과 예측, 2017-2031년
제5장 주요 인사이트
주요 업계 이벤트
세계에서 비만의 유병률과 발생률
주요 지역/세계의 규제 시나리오
업계에 대한 COVID-19 팬데믹의 영향
제6장 세계 시장의 분석과 예측 : 기간별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 기간별, 2017-2031년
6개월 미만
6개월
6개월 이상
시장의 매력 분석 : 기간별
제7장 세계 시장의 분석과 예측 : 유형별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 유형별, 2017-2031년
유체 충전 풍선
가스 충전 풍선
시장의 매력 분석 : 유형별
제8장 세계 시장의 분석과 예측 : 투여별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 투여별, 2017-2031년
내시경검사
삼킴 가능
시장의 매력 분석 : 투여별
제9장 세계 시장의 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과/발전
시장 금액 예측 : 최종사용자별, 2017-2031년
병원
외래 수술 센터
전문 클리닉
시장의 매력 분석 : 최종사용자별
제10장 세계 시장의 분석과 예측 : 지역별
주요 조사 결과
시장 금액 예측 : 지역별
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업의 계층 및 규모별)
시장 점유율 분석 : 기업별(2022년)
기업 개요
Apollo Endosurgery, Inc.
ReShape Lifesciences, Inc.
Spatz FGIA, Inc.
Allurion Sas
ENDALIS
Helioscopie
LEXEL SRL
CSC MEDSIL
KSA
영문 목차
영문목차
Intragastric Balloons Market - Scope of Report
TMR's report on the global intragastric balloons market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global intragastric balloons market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global intragastric balloons market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the intragastric balloons market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global intragastric balloons market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global intragastric balloons market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global intragastric balloons market.
The report delves into the competitive landscape of the global intragastric balloons market. Key players operating in the global intragastric balloons market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global intragastric balloons market profiled in this report.
Key Questions Answered in Global intragastric balloons Market Report:
What is the sales/revenue generated by intragastric balloons across all regions during the forecast period?
What are the opportunities in the global intragastric balloons market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2031?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Intragastric Balloons Market - Research Objectives and Research Approach
The comprehensive report on the global intragastric balloons market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global intragastric balloons market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global intragastric balloons market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Intragastric Balloons Market
4. Market Overview
4.1. Introduction
4.1.1. Duration Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Intragastric Balloons Market Analysis and Forecast, 2017-2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Industry Events
5.2. Prevalence and Incidence of Obesity in the World
5.3. Regulatory Scenarion in Key Regions/Globally
5.4. Covid-19 Pandemic Impact on Industry
6. Global Intragastric Balloons Market Analysis and Forecast, by Duration
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Duration, 2017-2031
6.3.1. <6 Months
6.3.2. 6 Months
6.3.3. >6 Months
6.4. Market Attractiveness Analysis, by Duration
7. Global Intragastric Balloons Market Analysis and Forecast, by Type
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Type, 2017-2031
7.3.1. Fluid-filled Balloons
7.3.2. Gas-filled Balloons
7.4. Market Attractiveness Analysis, by Type
8. Global Intragastric Balloons Market Analysis and Forecast, by Administration
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Administration, 2017-2031
8.3.1. Endoscopy
8.3.2. Swallowable
8.4. Market Attractiveness Analysis, by Administration
9. Global Intragastric Balloons Market Analysis and Forecast, by End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017-2031
9.3.1. Hospitals
9.3.2. Ambulatory Surgical Centers
9.3.3. Specialty Clinics
9.4. Market Attractiveness Analysis, by End-user
10. Global Intragastric Balloons Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness Analysis, by Region
11. North America Intragastric Balloons Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Duration, 2017-2031
11.2.1. <6 Months
11.2.2. 6 Months
11.2.3. >6 Months
11.3. Market Value Forecast, by Type, 2017-2031
11.3.1. Fluid-filled Balloons
11.3.2. Gas-filled Balloons
11.4. Market Value Forecast, by Administration, 2017-2031
11.4.1. Endoscopy
11.4.2. Swallowable
11.5. Market Value Forecast, by End-user, 2017-2031
11.5.1. Hospitals
11.5.2. Ambulatory Surgical Centers
11.5.3. Specialty Clinics
11.6. Market Value Forecast, by Country, 2017-2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Duration
11.7.2. By Type
11.7.3. By Administration
11.7.4. By End-user
11.7.5. By Country
12. Europe Intragastric Balloons Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Duration, 2017-2031
12.2.1. <6 Months
12.2.2. 6 Months
12.2.3. >6 Months
12.3. Market Value Forecast, by Type, 2017-2031
12.3.1. Fluid-filled Balloons
12.3.2. Gas-filled Balloons
12.4. Market Value Forecast, by Administration, 2017-2031
12.4.1. Endoscopy
12.4.2. Swallowable
12.5. Market Value Forecast, by End-user, 2017-2031
12.5.1. Hospitals
12.5.2. Ambulatory Surgical Centers
12.5.3. Specialty Clinics
12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Italy
12.6.5. Spain
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Duration
12.7.2. By Type
12.7.3. By Administration
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Intragastric Balloons Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Duration, 2017-2031
13.2.1. <6 Months
13.2.2. 6 Months
13.2.3. >6 Months
13.3. Market Value Forecast, by Type, 2017-2031
13.3.1. Fluid-filled Balloons
13.3.2. Gas-filled Balloons
13.4. Market Value Forecast, by Administration, 2017-2031
13.4.1. Endoscopy
13.4.2. Swallowable
13.5. Market Value Forecast, by End-user, 2017-2031
13.5.1. Hospitals
13.5.2. Ambulatory Surgical Centers
13.5.3. Specialty Clinics
13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Duration
13.7.2. By Type
13.7.3. By Administration
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Latin America Intragastric Balloons Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Duration, 2017-2031
14.2.1. <6 Months
14.2.2. 6 Months
14.2.3. >6 Months
14.3. Market Value Forecast, by Type, 2017-2031
14.3.1. Fluid-filled Balloons
14.3.2. Gas-filled Balloons
14.4. Market Value Forecast, by Administration, 2017-2031
14.4.1. Endoscopy
14.4.2. Swallowable
14.5. Market Value Forecast, by End-user, 2017-2031
14.5.1. Hospitals
14.5.2. Ambulatory Surgical Centers
14.5.3. Specialty Clinics
14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Market Attractiveness Analysis
14.7.1. By Duration
14.7.2. By Type
14.7.3. By Administration
14.7.4. By End-user
14.7.5. By Country/Sub-region
15. Middle East & Africa Intragastric Balloons Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Duration, 2017-2031
15.2.1. <6 Months
15.2.2. 6 Months
15.2.3. >6 Months
15.3. Market Value Forecast, by Type, 2017-2031
15.3.1. Fluid-filled Balloons
15.3.2. Gas-filled Balloons
15.4. Market Value Forecast, by Administration, 2017-2031
15.4.1. Endoscopy
15.4.2. Swallowable
15.5. Market Value Forecast, by End-user, 2017-2031
15.5.1. Hospitals
15.5.2. Ambulatory Surgical Centers
15.5.3. Specialty Clinics
15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Market Attractiveness Analysis
15.7.1. By Duration
15.7.2. By Type
15.7.3. By Administration
15.7.4. By End-user
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (by tier and size of companies)
16.2. Market Share Analysis, by Company (2022)
16.3. Company Profiles
16.3.1. Apollo Endosurgery, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. ReShape Lifesciences, Inc.
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Spatz FGIA, Inc.
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Allurion S.a.s.
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. ENDALIS
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Helioscopie
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. LEXEL S.R.L.
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. CSC MEDSIL
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
